ERBB2 and breast carcinoma: Again, concordant with our findings, Nair et al. [25] described a tendency towards poor patient prognosis in cancers with high ACE2 expression levels in an analysis of RNA expression data from a set of 2730 breast cancer patients, enriched for HER2 positive cases.